Literature DB >> 15863391

Caffeine inhibits cytokine expression in lymphocytes.

M Ritter1, K Hohenberger, P Alter, M Herzum, J Tebbe, M Maisch.   

Abstract

Caffeine alters intracellular calcium signalling patterns in lymphocytes which are important for the specific regulation of activation and effector function in lymphocytes. The effect of caffeine on calcium signalling is probably mediated via a ryanodine receptor type 3 dependent intracellular calcium store which releases calcium after exposure to caffeine. Also, caffeine decreases lymphocyte cytotoxicity against allogenic myocyte. Which cytotoxic mechanisms are actually altered by caffeine is unknown. In mouse splenocyte cultures containing about 87% lymphocytes we show that concanavalin A (ConA, 5 microg/ml) stimulated cells increase the expression of TNF-alpha, IL-2 and IFN-gamma (ELISA) significantly. Caffeine (3.75 mM) inhibits cytokine expression of ConA stimulated cells almost completely. Ryanodine (1 microM) specifically blocks ryanodine receptors and thereby prevents caffeine induced calcium release. In our experiments, however, ryanodine has no effect on ConA stimulated IL-2 and IFN-gamma expression and only suppresses TNF-alpha expression by 20%. Furthermore, ryanodine does not prevent the inhibitory effect of caffeine on TNF-alpha, IL-2 and IFN-gamma expression in stimulated effector cells. We postulate that caffeine suppresses cytokine expression and thereby contributes to decreased cytotoxicity of lymphocytes against allogenic myocytes. The ryanodine receptor dependent intracellular calcium store does not seem to play a significant role in this process. Possibly, the blockade of IP3 receptors by caffeine is more important for cytokine suppression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863391     DOI: 10.1016/j.cyto.2004.12.013

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

Review 1.  Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?

Authors:  Shani Dahan; Yahel Segal; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2017-04-13       Impact factor: 20.543

2.  Sleep variability, health-related practices, and inflammatory markers in a community dwelling sample of older adults.

Authors:  Michele L Okun; Charles F Reynolds; Daniel J Buysse; Timothy H Monk; Sati Mazumdar; Amy Begley; Martica Hall
Journal:  Psychosom Med       Date:  2010-11-19       Impact factor: 4.312

3.  Caffeine affects CD8+ lymphocyte apoptosis and migration differently in naïve and familiar individuals following moderate intensity exercise.

Authors:  James W Navalta; Elizabeth A Fedor; Mark A Schafer; T Scott Lyons; Ramires A Tibana; Guilherme B Pereira; Jonato Prestes
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

4.  Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants.

Authors:  Raul Chavez Valdez; Rajni Ahlawat; Marsha Wills-Karp; Amy Nathan; Tarrah Ezell; Estelle B Gauda
Journal:  J Pediatr       Date:  2010-08-06       Impact factor: 4.406

Review 5.  Caffeine therapy in preterm infants.

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  World J Clin Pediatr       Date:  2015-11-08

Review 6.  Modulators affecting the immune dialogue between human immune and colon cancer cells.

Authors:  Meir Djaldetti; Hanna Bessler
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

7.  Caffeine modulates glucocorticoid-induced expression of CTGF in lung epithelial cells and fibroblasts.

Authors:  Markus Fehrholz; Kirsten Glaser; Christian P Speer; Silvia Seidenspinner; Barbara Ottensmeier; Steffen Kunzmann
Journal:  Respir Res       Date:  2017-03-23

8.  Caffeine to prevent respiratory failure and improve outcome in infant pertussis.

Authors:  John Evered; Eric Pfeifer; Matthew Gracianette
Journal:  BMJ Case Rep       Date:  2018-03-28

Review 9.  Caffeine and its main targets of colorectal cancer.

Authors:  Wen-Qi Cui; Shi-Tong Wang; Dan Pan; Bing Chang; Li-Xuan Sang
Journal:  World J Gastrointest Oncol       Date:  2020-02-15

10.  Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson's Disease.

Authors:  Noa Liscovitch; Leon French
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.